ATE427320T1 - Behandlung von infektionen verursacht von mikroorganismen - Google Patents

Behandlung von infektionen verursacht von mikroorganismen

Info

Publication number
ATE427320T1
ATE427320T1 AT02777534T AT02777534T ATE427320T1 AT E427320 T1 ATE427320 T1 AT E427320T1 AT 02777534 T AT02777534 T AT 02777534T AT 02777534 T AT02777534 T AT 02777534T AT E427320 T1 ATE427320 T1 AT E427320T1
Authority
AT
Austria
Prior art keywords
microorganisms
treatment
infections caused
antibody
daptomycin
Prior art date
Application number
AT02777534T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Application granted granted Critical
Publication of ATE427320T1 publication Critical patent/ATE427320T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT02777534T 2001-11-22 2002-11-13 Behandlung von infektionen verursacht von mikroorganismen ATE427320T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0127983.5A GB0127983D0 (en) 2001-11-22 2001-11-22 Treatment of micro-organism infection

Publications (1)

Publication Number Publication Date
ATE427320T1 true ATE427320T1 (de) 2009-04-15

Family

ID=9926237

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777534T ATE427320T1 (de) 2001-11-22 2002-11-13 Behandlung von infektionen verursacht von mikroorganismen

Country Status (18)

Country Link
US (3) US20050118162A1 (de)
EP (2) EP1446425B1 (de)
JP (1) JP2005511645A (de)
CN (2) CN101254304A (de)
AT (1) ATE427320T1 (de)
AU (2) AU2002339159B2 (de)
BR (1) BR0214363A (de)
CA (1) CA2465072A1 (de)
DE (1) DE60231825D1 (de)
DK (1) DK1446425T3 (de)
ES (1) ES2322756T3 (de)
GB (1) GB0127983D0 (de)
NO (2) NO20042604L (de)
NZ (1) NZ533623A (de)
PL (1) PL369536A1 (de)
PT (1) PT1446425E (de)
RU (1) RU2303460C2 (de)
WO (1) WO2003046007A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5248033B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
JP5248032B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
WO2008132174A1 (en) * 2007-04-27 2008-11-06 Novartis Ag An immunoglobulin composition
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
MX2011012248A (es) 2009-05-18 2012-02-29 Univ Wuerzburg J Maximilians Anticuerpos o sus fragmentos dirigidos contra un epitope de staphylococcus aureus de isaa o isab.
JP6192294B2 (ja) * 2009-07-15 2017-09-06 エーアイエムエム セラピューティクス ベー．フェー． グラム陽性菌特異的結合化合物
US9005579B2 (en) * 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
JP5996544B2 (ja) 2010-10-15 2016-09-21 クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ 眼球アクセス用装置
CN103168046A (zh) * 2010-10-20 2013-06-19 米迪缪尼有限公司 用于加工包涵体的方法
BR112015027762A2 (pt) 2013-05-03 2017-08-29 Clearside Biomedical Inc Aparelho e métodos para injeção ocular
RU2572341C2 (ru) * 2013-09-20 2016-01-10 Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА
EP3452165A1 (de) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systeme und verfahren zur verabreichung eines augenmedikaments
IL305537B2 (en) 2016-08-12 2025-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a needle for administering a drug
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0779819A1 (de) * 1994-09-06 1997-06-25 Galagen Inc. Therapeutische behandlung von clostridium difficile verbundene krankheiten
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
GB9806762D0 (en) 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection

Also Published As

Publication number Publication date
PL369536A1 (en) 2005-05-02
CN101254304A (zh) 2008-09-03
RU2004118716A (ru) 2005-03-27
NO20042604L (no) 2004-06-21
US20050118162A1 (en) 2005-06-02
RU2303460C2 (ru) 2007-07-27
WO2003046007A2 (en) 2003-06-05
AU2002339159A1 (en) 2003-06-10
ES2322756T3 (es) 2009-06-26
EP1446425B1 (de) 2009-04-01
PT1446425E (pt) 2009-07-01
AU2008212001A1 (en) 2008-09-25
DK1446425T3 (da) 2009-07-20
US20070202116A1 (en) 2007-08-30
WO2003046007A3 (en) 2004-03-11
NZ533623A (en) 2005-12-23
GB0127983D0 (en) 2002-01-16
EP1964851A1 (de) 2008-09-03
NO20081575L (no) 2004-06-21
BR0214363A (pt) 2004-10-26
EP1446425A2 (de) 2004-08-18
CA2465072A1 (en) 2003-06-05
CN1589280A (zh) 2005-03-02
US20080171054A1 (en) 2008-07-17
AU2002339159B2 (en) 2008-06-05
CN100371348C (zh) 2008-02-27
DE60231825D1 (de) 2009-05-14
JP2005511645A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
NO20081575L (no) Behandling av mikroorganismeinfeksjoner
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
DK1644504T3 (da) Faktor VII- eller -VIIA-Gla-domænevarianter
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
IL132933A0 (en) Composition for the treatment of diarrheal disease
ATE482272T1 (de) Zytokinproteinfamilie
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
DE69330268D1 (de) Hämoregulierende peptide
GB0203419D0 (en) Peptide
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
SE9700244D0 (sv) Novel antibacterial protein
NZ508812A (en) Peptides for the prevention or treatment of HIV
WO2004042043A3 (en) Crystal structures of bacterial ribulose-phosphate 3-epimerases
WO2001058471A3 (en) Novel amino acid and peptide inhibitors of staphylococcus virulence
ATE212839T1 (de) Hämoregulatorische verbindungen
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
WO2003048187A3 (en) Peptides and use thereof in therapeutic agents against hiv infection
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
DE602004003508D1 (de) Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung
CO4820441A1 (es) Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal
MX9800686A (es) Nueva proteina hmw humana mp52s.
WO2003055904A3 (en) Peptidyl-trna hydrolase from pseudomonas aeruginosa
WO2004042044A3 (en) Crystal structures of bacterial guanylate kinases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1446425

Country of ref document: EP

REN Ceased due to non-payment of the annual fee